Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Analysis of Research Publications on Pharmacogenomics of Sulphonylurea - A Scientometric Study

Author(s): Pugazhenthan Thangaraju*, Himanshu Nirmal Chandu, Hemasri Velmurugan, Pankaj Kumar Kannauje and R. Arun Kumar

Volume 20, Issue 5, 2024

Published on: 12 October, 2023

Article ID: e121023222120 Pages: 7

DOI: 10.2174/0115733998254570230923171449

Price: $65

Abstract

This study analysed pharmacogenomics studies on sulfonylurea research publications using the Pubmed and Scopus databases. In the end, 65 publications from the years 2015 to 2021 were noticed. The objective of this study was to analyse these studies using scientometric tools, such as frequency counts, percentages, relative growth rates, doubling times, and collectively. A maximum of 19 (29.23%) research publications were contributed during the 2020 research period. The relative growth rate tends to decrease from 2015 to 2020 and the doubling time tends to increase and decrease after 2020. Up to 2 (3.08%) research publications were contributed by Ewan R. Pearson and Chen each. The top authors have an average degree of collaboration of 0.90 and 41 (63.83%) of their research publications are articles. The United States is the major contributor with 19 (29.23%) pharmacogenomics research publications on sulfonylureas. Although the United States is the most prolific country in sulfonylurea pharmacogenomics research, there are few Indian institutions that are not listed among the most prolific institutions.

[1]
de Solla Price D. Editorial statements. Scientometrics 1978; 1(1): 3-8.
[http://dx.doi.org/10.1007/BF02016836]
[2]
Bookstein A. The bibliometric distributions. Libr Q 1976; 46(4): 416-23.
[http://dx.doi.org/10.1086/620585]
[3]
Pritchard A. Statistical bibliography or bibliometrics? J Doc 1969; 25: 348-9.
[4]
Ingwersen P, Christensen FH. Data set isolation for bibliometric online analyses of research publications: Fundamental methodological issues. J Am Soc Inf Sci 1997; 48(3): 205-17.
[http://dx.doi.org/10.1002/(SICI)1097-4571(199703)48:3<205:AID-ASI3>3.0.CO;2-0]
[5]
Becquemont L. Pharmacogenomics of adverse drug reactions: Practical applications and perspectives. Pharmacogenomics 2009; 10(6): 961-9.
[http://dx.doi.org/10.2217/pgs.09.37] [PMID: 19530963]
[6]
Sheffield LJ, Phillimore HE. Clinical use of pharmacogenomic tests in 2009. Clin Biochem Rev 2009; 30(2): 55-65.
[PMID: 19565025]
[7]
Hauser AS, Chavali S, Masuho I, et al. Pharmacogenomics of GPCR drug targets. Cell 2018; 172(1-2): 41-54.e19.
[http://dx.doi.org/10.1016/j.cell.2017.11.033] [PMID: 29249361]
[8]
US Food and Drug Administration (USFDA). Guidance for industry pharmacogenomic data submissions. 2005. Available from: https://www.fda.gov/
[9]
Squassina A, Manchia M, Manolopoulos VG, et al. Realities and expectations of pharmacogenomics and personalized medicine: Impact of translating genetic knowledge into clinical practice. Pharmacogenomics 2010; 11(8): 1149-67.
[http://dx.doi.org/10.2217/pgs.10.97] [PMID: 20712531]
[10]
Huser V, Cimino JJ. Providing pharmacogenomics clinical decision support using whole genome sequencing data as input. AMIA Jt Summits Transl Sci Proc 2013; 2013: 81.
[PMID: 24303303]
[11]
Coll RC, Robertson AAB, Chae JJ, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 2015; 21(3): 248-55.
[http://dx.doi.org/10.1038/nm.3806] [PMID: 25686105]
[12]
Sweileh WM, Zyoud SH, Al-Jabi SW, Sawalha AF. Bibliometric analysis of diabetes mellitus research output from Middle Eastern Arab countries during the period (1996–2012). Scientometrics 2014; 101(1): 819-32.
[http://dx.doi.org/10.1007/s11192-014-1361-0]
[13]
Rasolabadi M, Khaledi S, Ardalan M, Kalhor M, Penjvini S, Gharib A. Diabetes research in Iran: A scientometric analysis of publications output. Acta Inform Med 2015; 23(3): 160-4.
[http://dx.doi.org/10.5455/aim.2015.23.160-164] [PMID: 26236083]
[14]
Somogyi A, Schubert A. Short communication: Correlation between national bibliometric and health indicators: The case of diabetes. Scientometrics 2005; 62(2): 285-92.
[http://dx.doi.org/10.1007/s11192-005-0021-9]
[15]
Mahapatra M. On the validity of the theory of exponential growth of scientific literature. Proceedings of the 15th IASLIC conference. Bangalore. 1985; p. 6170.
[16]
Vivekanandhan S, Sivasamy K. Growth of pollution control research publications in India from Scopus database. 1991-2015: A scientometric study. E-Library Sci Res 2017; 5(3): 1-9.
[17]
Siva N, Vivekanandhan S, Rajendran P. Global research publications on hepatitis C from Scopus database 2009-2018: A scientometric study. Library Phil Prac 2019; p. 2454.
[18]
Subramanyam K. Bibliometric studies of research collaboration: A review. J Inf Sci 1983; 6(1): 33-8.
[http://dx.doi.org/10.1177/016555158300600105]
[19]
Sivasamy K, Vivekanandhan S. Environmental education research literature output in SCOPUS database (2009-2013): A bibliometric study. Int J Inf Sources Serv 2015; 2(2): 84-93.
[20]
Vivekanandhan S, Sivasamy K, Prabhakar S. Analysis of pollution control research output from Scopus database (1985-2014): A scientometric study. Lis Today 2016; 3(1-2): 32-41.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy